# Elicio Therapeutics, Inc. (ELTX) - Q4 2024 earnings

Reported March 31, 2025.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | $1.2M | Not available |
| EPS | $-1.02 | $-0.94 |

Earnings filing reader: [8-K 0001601485-25-000046](https://www.opencapital.sh/filings/0001601485-25-000046)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001601485-25-000046.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1601485/0001601485-25-000046-index.htm)
Periodic report: 10-K - https://www.sec.gov/Archives/edgar/data/1601485/0001601485-25-000049-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/eltx/earnings/q4-2024